SCHEMBL1700484

SCHEMBL1700484

CN(Cl)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11191472 0.75
Acetic Acid SCHEMBL7621796 0.75
SCHEMBL6726899 0.75
SCHEMBL9877 0.75
SCHEMBL2875093 0.73
Dimethylcarbate SCHEMBL15360 0.73
Dimethylcarbate SCHEMBL1232328 0.73
SCHEMBL6512198 0.72
SCHEMBL2708756 0.72
SCHEMBL6972746 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114981270-A MLL1 inhibitors and anticancer agents 诺华公司 2022-08-30 CN disclosed
CN-102686564-B Pyrrolidine derivatives HOFFMANN LA ROCHE 2014-06-25 CN disclosed
EP-2566335-A1 CONTROLLED RELEASE FROM MACROMOLECULAR CONJUGATES Prolynx Llc (US) 2013-03-13 EP disclosed
EP-2566334-A1 CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS Prolynx Llc (US) 2013-03-13 EP disclosed
WO-2011140393-A1 CONTROLLED RELEASE FROM MACROMOLECULAR CONJUGATES PROLYNX LLC (US) 2011-11-10 WO disclosed
WO-2011140392-A1 CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS PROLYNX LLC (US) 2011-11-10 WO disclosed
US-20100173935-A1 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia ASTRAZENECA AB (SE) 2010-07-08 US disclosed
CN-101501024-A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia ASTRAZENECA AB (SE) 2009-08-05 CN disclosed
EP-2035412-A1 MUSCARINIC RECEPTOR AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA Astra Zeneca AB (SE) 2009-03-18 EP disclosed
US-20080306069-A1 Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S ASTEX THERAPEUTICS LIMITED (UK) 2008-12-11 US disclosed
US-5977089-A ORALLY ADMINISTERING TENOFOVIR DERIVATIVES GILEAD SCIENCES, INC. (US) 1999-11-02 US disclosed
US-5922695-A COMPOUNDS CONTAINING CARBONATE OR CARBAMATE GROUPS GILEAD SCIENCES, INC. (US) 1999-07-13 US disclosed
EP-0915894-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1999-05-19 EP disclosed
WO-1998004569-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1998-02-05 WO disclosed
EP-0130119-B1 (ACYLOXYALKOXY) CARBONYL DERIVATIVES AS BIOREVERSIBLE PRODRUG MOIETIES FOR PRIMARY AND SECONDARY AMINE FUNCTIONS IN DRUGS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES MERCK & CO. INC. (US) 1988-11-09 EP disclosed
US-4760057-A (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs MERCK & CO., INC. (US) 1988-07-26 US disclosed
US-4548929-A Insecticidal and nematocidal heterobicyclic hydroximinates, thiohydroximidates, and carbamate esters, composition, and method of use thereof SDS BIOTECH CORPORATION (US) 1985-10-22 US disclosed
EP-0130119-A2 (Acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives MERCK & CO. INC. (US) 1985-01-02 EP disclosed
US-4479002-A CHEMICAL INTERMEDIATES FOR INSECTICIDES, PESTICIDES UNION CARBIDE CORPORATION (US) 1984-10-23 US disclosed
US-4424213-A PESTICIDES SDS BIOTECH CORPORATION (US) 1984-01-03 US disclosed